Hubei Goto Biopharm Group Co Ltd
300966
Company Profile
Business description
Hubei Goto Biopharm Group Co Ltd is engaged in the research, development, production and sales of steroidal drug raw materials. The company's main products are starting materials, intermediates and active pharmaceutical ingredients required for the production of steroid drugs.
Contact
Jiangshan South Road, Wolong Avenue
33rd Floor, Building 1, Global Financial City
Fancheng District, Hubei Province
Xiangyang441057
CHNT: +86 7103523126
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
893
Stocks News & Analysis
stocks
Lithium’s latest drop and what it means for ASX investors
Volatility returns to the lithium market.
stocks
Major ASX miner remains overvalued following production update
Iron ore strength keeps production on track despite lower copper output.
stocks
Ahead of earnings, is Alphabet stock a buy, a sell, or fairly valued?
From Google Cloud to Gemini user retention, here’s what we expect from Alphabet’s earnings report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,980.60 | 37.10 | 0.41% |
| CAC 40 | 8,340.11 | 1.30 | 0.02% |
| DAX 40 | 24,846.69 | 15.71 | 0.06% |
| Dow JONES (US) | 51,839.26 | 307.16 | -0.59% |
| FTSE 100 | 10,524.76 | 75.61 | -0.71% |
| HKSE | 25,150.75 | 7.70 | 0.03% |
| NASDAQ | 25,508.07 | 12.17 | -0.05% |
| Nikkei 225 | 65,740.43 | 1,599.31 | 2.49% |
| NZX 50 Index | 13,705.79 | 9.76 | 0.07% |
| S&P 500 | 7,443.28 | 14.41 | -0.19% |
| S&P/ASX 200 | 8,796.30 | 39.30 | 0.45% |
| SSE Composite Index | 3,819.66 | 23.37 | 0.62% |